A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Regor Pharmaceuticals Inc.
Fate Therapeutics
Epsilogen Ltd
IDEAYA Biosciences
Cogent Biosciences, Inc.
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
Eli Lilly and Company
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
BeOne Medicines
Eli Lilly and Company
Seagen Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Seagen Inc.
Fusion Pharmaceuticals Inc.
Dren Bio
National Institutes of Health Clinical Center (CC)
Risen (Suzhou) Pharma Tech Co., Ltd.
NextCure, Inc.
NeoTX Therapeutics Ltd.
SystImmune Inc.
NiKang Therapeutics, Inc.
EtiraRx Australia Pty Ltd
Exelixis
Numab Therapeutics AG
Lyell Immunopharma, Inc.
AstraZeneca
NextPoint Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Black Diamond Therapeutics, Inc.
Theratechnologies
Exelixis
Compugen Ltd